|
Real-time Estimate
Cboe BZX
19:47:53 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 26.98 USD | +0.47% |
|
+12.42% | -22.03% |
| 10-29 | Viking Therapeutics, Inc., Q3 2026 Earnings Call, Oct 28, 2026 | |
| 10-29 | Earnings Flash (VKTX) Viking Therapeutics Posts Q3 Loss -$1.55, vs. FactSet Est of -$1.06 Loss | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.47% | +12.42% | -15.86% | -17.15% | -22.03% | -28.14% | +186.33% | +346.74% | +2,463.55% | 3.43B | |
| -0.62% | +0.50% | -11.61% | +12.26% | +56.67% | +33.92% | +60.07% | +2.90% | - | 64.38B | |
| +0.92% | +3.86% | -4.06% | +8.81% | +13.34% | +15.66% | +85.73% | +207.15% | +5,702.86% | 56.16B | |
| +0.44% | +1.84% | +11.86% | +12.84% | +19.64% | +15.22% | +106.55% | -15.70% | +244.43% | 54.16B | |
| -3.20% | -4.12% | -0.38% | +12.64% | +18.82% | +23.73% | +51.19% | +3.46% | +273.35% | 45.33B | |
| +0.08% | -1.13% | +2.03% | +15.93% | +22.90% | +21.14% | +100.09% | +4.45% | +1,023.29% | 42.25B | |
| -1.12% | +1.07% | -7.92% | -1.65% | +137.29% | +221.05% | +929.97% | +507.33% | - | 40.78B | |
| +2.98% | +47.39% | +66.33% | +111.33% | +92.25% | +111.85% | +95.73% | +35.83% | +248.57% | 33.8B | |
| +1.22% | -1.39% | +7.10% | +6.44% | +11.15% | +13.92% | +46.95% | +16.23% | +160.92% | 32.25B | |
| -1.29% | -1.72% | -16.86% | +12.95% | +41.48% | +21.00% | -6.85% | -62.43% | - | 23.57B | |
| -1.20% | +0.23% | -10.15% | -4.88% | -7.23% | -15.62% | -5.29% | -67.80% | - | 22.39B | |
| +1.68% | +21.81% | -0.34% | +12.08% | -34.64% | -41.43% | +377.96% | +266.36% | +776.39% | 24.37B | |
| -3.56% | -1.91% | +5.17% | +13.51% | +16.88% | +13.11% | +171.48% | +189.93% | +2,161.99% | 18.95B | |
| -5.19% | +3.92% | +21.66% | +52.97% | +79.92% | +100.38% | +118.15% | -18.48% | +372.98% | 17.95B | |
| +0.60% | +3.35% | +16.72% | +27.61% | +40.29% | +44.41% | +87.33% | -15.50% | +111.50% | 16.88B | |
| +8.07% | +10.74% | +22.34% | +27.68% | +63.04% | +83.51% | +253.06% | +229.31% | +574.79% | 16.4B | |
| -0.60% | +3.83% | +10.91% | +0.65% | - | - | - | - | - | 16.62B | |
| -2.76% | +14.04% | +24.29% | +27.64% | +15.95% | +27.79% | -11.28% | -26.87% | +163.18% | 16.14B | |
| -4.03% | +2.59% | -0.42% | +10.19% | +180.86% | +166.14% | +341.90% | +1,407.09% | +787.81% | 15.77B | |
| -7.05% | +7.85% | -10.96% | +64.64% | +23.49% | -15.47% | - | - | - | 14.05B | |
| Average | -0.69% | +6.42% | +5.49% | +20.32% | +40.53% | +42.75% | +166.06% | +167.22% | +1,076.11% | 28.78B | |
| Weighted average by Cap. | -0.44% | +5.03% | +4.77% | +19.48% | +41.44% | +45.01% | +164.14% | +122.85% | +1,280.04% |
- Stock Market
- Stocks
- VKTX Stock
- Sector Viking Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
